Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph phase_1
1
25%
Ph phase_4
1
25%
Ph not_applicable
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

unknown250%
recruiting125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
terminatedphase_1

Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury

NCT05204836
recruitingnot_applicable

Continuous Passive Motion Versus Heterotopic Ossification

NCT05906056
unknownphase_4

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid

NCT04719650
unknownphase_2

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

NCT04325776

Clinical Trials (4)

Showing 4 of 4 trials
NCT05204836Phase 1

Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury

Terminated
NCT05906056Not Applicable

Continuous Passive Motion Versus Heterotopic Ossification

Recruiting
NCT04719650Phase 4

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid

Unknown
NCT04325776Phase 2

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4